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PURPOSE. To investigate the association of single-nucleotide
polymorphisms (SNPs) in the manganese superoxide dis-
mutase (MnSOD) and two chemokine genes (CCL2 and CCL5)
in patients with anterior uveitis (AU).
METHODS. Seventy-nine Chinese patients with acute AU were
recruited, and genotyping of four SNPs including MnSOD 47,
CCL2 2518, CCL2 2076, and CCL5 403 alleles was per-
formed with SNP genotyping assays. The genotype and allele
frequencies were compared between patients with AU and 206
healthy control subjects. Analyses were also stratified accord-
ing to the HLA-B27 status of the patients.
RESULTS. There were significant increases in the frequency of
the AA homozygosity in the MnSOD 47 SNP (P  0.049) and in
the CCL2 2518G allele frequency and GG homozygosity in
patients with AU compared with control subjects (P  0.017
and P  0.024, respectively). No significant association was
found between AU with the CCL2 2076 and CCL5 403
SNPs. Subgroup analyses showed that the MnSOD 47A poly-
morphism was significantly associated with AU in HLA-B27–
positive patients, but not in HLA-B27–negative patients,
whereas the CCL2 2518G polymorphism was significantly
associated with AU in HLA-B27–negative patients, but not in
HLA-B27–positive patients.
CONCLUSIONS. The 47A polymorphism in the MnSOD gene and
the 2518G polymorphism in the CCL2 gene are associated
with the development of AU in HLA-B27–positive and –nega-
tive Chinese patients, respectively. Further studies to evaluate
the interactions of the HLA-B27 status and these SNPs are
warranted. (Invest Ophthalmol Vis Sci. 2009;50:5596–5600)
DOI:10.1167/iovs.09-3661
Uveitis is a diverse group of intraocular inflammatory dis-eases and can be anatomically classified as anterior, inter-
mediate, posterior, and pan uveitis. Anterior uveitis (AU) is the
most common form, accounting for 50% to 92% of cases in
most Western countries and 28% to 50% in Asian countries.1
AU most commonly develops as an isolated idiopathic disease
but can also be part of various systemic syndromes such as
ankylosing spondylitis (AS), Behçet’s disease, juvenile idio-
pathic arthritis, and inflammatory bowel diseases. Although
most cases of AU have relatively good prognosis with treat-
ment, sight threatening complications may also develop such
as cataract, glaucoma, cystoid macular edema, and epiretinal
membrane.
The exact pathogenesis of most cases of AU is unknown and
human and animal studies have suggested that the disease is
regulated by various endogenous immune mechanisms and
influenced by genetic and environmental factors.2,3 The most
common and strongest genetic association of the disease have
been with class I HLA genes of the major histocompatibility
complex (MHC) in chromosome 6.4,5 In recent years, non-
MHC gene variants, such as chemokines and antioxidant en-
zyme genes polymorphisms, have also been implicated as hav-
ing important roles in the pathogenesis of AU.6–11 Chemokines
are low-molecular-weight proteins that are potent inflamma-
tory mediators with abilities to attract leukocytes and have a
critical role in the development of uveitis.9–11 Studies have
shown that the levels of two chemokines, chemokine (C-C)
motif-2 (CCL2)/monocyte chemotactic protein-1 (MCP-1), and
chemokine (C-C) motif-5 (CCL5), were significantly increased
during the active stage of AU and correlated with the clinical
severity of the disease.10 Similar findings have also been noted
in experimental autoimmune uveitis (EAU).9,11 Several single
nucleotide polymorphisms (SNPs) in the promoter regions of
these chemokine genes have been found to be associated with
various inflammatory diseases including those in the CCL2
gene (2518A/G and 2076A/T) and the CCL5 gene (403C/
T).12,13 Moreover, associations have been identified between
CCL2 2518A/G, CCL2 2076A/T, and CCL5 403C/T poly-
morphisms and various types of uveitis.6,14–16
In addition to various chemokines, it has been suggested
that reactive oxygen species are involved in the pathogenesis
of Behçet’s disease, in which uveitis is one of the typical
manifestations. Enhanced superoxide generation and de-
creased superoxide scavenging activity of peripheral blood
leukocytes have been found in patients with Behçet’s dis-
ease.17,18 The reduced superoxide scavenging activity will lead
to accumulation of superoxide radical, which in turn induces
tissue damage. Manganese superoxide dismutase (MnSOD), a
key antioxidant enzyme, scavenges superoxides and inhibits
the formation of peroxynitrite, thereby suppressing the result-
ing tissue injury. An alanine-to-valine substitution at codon 16
of the human MnSOD gene has been reported to lead to a
changes in MnSOD activity in mitochondria.19,20 On the other
hand, MnSOD can be induced by proinflammatory cytokines,
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such as tumor necrosis factor and interleukin-1,21,22 and can
lead to tissue damage in chronic inflammatory diseases. Re-
cently, the MnSOD 47A (Val16) allele was found to be associ-
ated with the development of Behçet’s disease in Japanese but
not in Chinese patients.22,23 The purpose of our study was to
determine the association of various polymorphisms in the
MnSOD and chemokine genes in Chinese patients with AU.
METHODS
Study Design and Subjects
The study was of a case–control design, in which patients with AU
were recruited from Hong Kong Eye Hospital. The protocol was
approved by an institutional review board and the study was con-
ducted in accordance with the tenets of the Declaration of Helsinki.
Informed consent was obtained from all subjects.
All patients underwent a detailed ocular examination, and clinical
details were extracted from the case notes. These included sex, med-
ical history such as systemic illness, age at initial presentation, lateral-
ity, pattern of anterior uveitis (acute, recurrent or chronic), clinical
features and complications of AU, visual acuity, and intraocular pres-
sure. The definition of uveitis was based on the Standardization Uveitis
Nomenclature (SUN) classification,24 with acute AU defined as AU
resolving completely within 3 months, chronic AU as AU not fully
resolved within 3 months, and recurrent AU as the development of AU
more than once. Patients with AU secondary to ocular or systemic
infections, Posner-Schlossman’s syndrome, Fuchs’ uveitis, and Behçet’s
disease and those unable to cooperate during ocular examination and
with chronic uveitis at the onset of the study were excluded. Two-
hundred six subjects 50 years of age or older, with no ophthalmic eye
disease except senile cataract, were included as control subjects.
DNA Extraction and Genotyping
Genomic DNA was extracted from EDTA-chelated peripheral whole
blood of all subjects using the commercial DNA extraction kit
(QIAampDNA Blood Mini Kit; Qiagen, Hilden, Germany) according to
the manufacturer’s instructions.
SNPs in four positions including MnSOD 47 (rs4880), CCL2 2518
and 2076 (rs1024611 and rs1024610, respectively), and CCL5 403
(rs2107538) were assessed by SNP genotyping assays (TaqMan; Ap-
plied Biosystems [ABI], Foster City, CA) according to the manufactur-
er’s instructions. All PCR amplification was performed with the follow-
ing thermal cycling conditions: 95°C for 10 minutes and 55 cycles of
92°C for 15 seconds and 60°C for 1 minute. HLA-B27 allele was
detected by nested PCR as described by Konno et al.25 The B locus of
HLA was first amplified. The B27 allele was then amplified from the
diluted PCR product of the B locus by using sequence-specific primers.
The B27 allele was further detected and confirmed as described pre-
viously.25 All PCR reactions were performed with Taq polymerase
(HotStarTaq Plus; Qiagen) in an automated thermal cycler (model
9700; ABI). Pre- and post-PCR plate readings were performed on a
sequence detection system (Prism 7000; ABI), and the allele types were
confirmed by the system software (Prism 7000 SDS software ver. 1.1;
ABI).
Statistical Analysis
Genotype frequencies of the SNPs in the control group were tested for
deviation from the Hardy-Weinberg equilibrium by 2 test. The geno-
type frequencies for each polymorphism were determined by direct
counting, and allele frequencies were calculated. The 2 test or Fisher
exact test was used to compare genotype and allele frequencies be-
tween patients with AU and controls. The influence of the SNPs on
different HLA-B27 statuses was determined by stratifying patients with
AU based on HLA-B27 status and compared them with the control
subjects. Odds ratios (OR) and 95% confidence intervals (CI) were
calculated; P  0.05 was considered significant.
RESULTS
Patient Demographics
Seventy-nine patients with acute AU were recruited. The
mean  SD age of the patients was 48.6  16.1 years (range,
18–83). There were 37 (46.8%) men and 42 (53.2%) women.
Fifty (63.3%) patients had unilateral uveitis, 16 (20.3%) had
uveitis in alternating eyes, and 13 (16.5%) had bilateral involve-
ment. Systemic diseases associated with the patients included
AS in 15 (19.0%) patients, psoriasis in 3 (3.8%), and ulcerative
colitis in 1 (1.2%) patient. None of the subjects had idiopathic
juvenile arthritis. Seventy-six (96.2%) patients had acute AU
only, of which 48 (60.8%) had recurrent episodes of AU, and 3
(3.8%) developed chronic AU after acute episodes of AU.
Associations between SNPs and AU
All genotype frequencies in the control subjects conformed to
Hardy-Weinberg equilibrium. For the MnSOD 47G/A SNP,
there was a significant increase in the frequency of AA homozy-
gosity in patients with AU compared with control subjects
(82.3% vs. 70.9%, P  0.049, OR1.91; Table 1). For the CCL2
gene, there was a significant increase in the frequencies of
CCL2 2518G allele and GG homozygosity in patients with AU
compared with control subjects (58.2% vs. 47.1%, P  0.017,
OR  1.57 and 35.4% vs. 22.3%, P  0.024, respectively). The
CCL2 2076TT homozygous genotype was not present in
patients with AU or control subjects and no significant differ-
ence in the genotype or allele frequencies was observed for
both the CCL2 2076A/T and the CCL5 403C/T SNPs in
patients with AU compared with control subjects.
Association of SNPs Genotypes and Allele
Frequencies Stratified by HLA-B27 Status
Thirty-six (45.6%) of the 79 patients with AU were HLA-B27–
positive, compared with 15 (6.4%) control subjects (2 test,
P  0.001). For the HLA-B27–positive patients with AU, signif-
icantly higher proportions of AA genotype and A allele fre-
quency were found with the MnSOD 47 SNP compared with
control subjects (Table 2; Fisher exact test, P  0.024 and P 
0.047, respectively), but no significant association was found
for the CCL2 2518 SNP. On the contrary, for HLA-B27–
negative patients with AU, significantly higher proportions of
GG genotype and G allele frequencies were found for the CCL2
2518 SNP compared with controls (Table 3; Fisher exact test,
P  0.003 and P  0.004, respectively), whereas no significant
association was found for the MnSOD 47 SNP. There was no
significant difference in the genotype and allele frequencies in
the CCL2 2076A/T and the CCL5 403C/T SNPs between
HLA-B27–positive patients and control subjects or between
HLA-B27–negative patients and control subjects.
DISCUSSION
In this study, we investigated in Chinese patients with acute
AU the association of four selected SNPs in the MnSOD, CCL2,
and CCL5 genes implicated in AU. Our results demonstrated
that two of the assessed SNPs were significantly present in
Chinese patients with AU. These included the 47A allele in the
MnSOD gene and the 2518G allele in the CCL2 gene. Our
finding of an association between polymorphism in the
MnSOD 47 SNP and AU is consistent with findings in a study in
Japanese patients by Nakao et al.,22 in which there were
significant increases in both the MnSOD 47 AA homozygous
genotype and A allele frequencies in patients with Behçet’s
disease compared with control subjects. The MnSOD gene is
located in the long arm of chromosome 6 (6q25). Enzymatic
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activity of MnSOD within the mitochondria is influenced by
transport efficiency of mitochondria targeting sequence (MTS)
in the mitochondrial membrane. Polymorphisms at position 47
in the structural part of the MnSOD gene were found to result
in the synthesis of either alanine (Ala) or valine (Val) in the
MnSOD MTS.19,26 In vitro study has shown that the Ala-MTS
forms an -helical structure and ensures rapid and complete
importation of MTS into mitochondria.20 In contrast, the Val-
MTS leads to the formation of a -sheet structure and its
transportation into mitochondria is partially stalled within the
narrow translocase of the inner mitochondrial membrane.20
The change of G-to-A nucleotide at position 47 of the MnSOD
gene results in the formation of the -sheet Val-MTS structure,
which leads to lower concentrations of MnSOD in the mito-
chondria and may subsequently increase the risk of AU due to
reduced resistance to oxidative stress.
In addition to the association of MnSOD polymorphism
with AU, our results also showed that the G allele at the CCL2
2518 position was associated with increased risk of AU com-
pared with the control. Previous studies have also similarly
demonstrated the association between the 2518G allele and
HLA-B27–associated acute AU,6 as well as immune-mediated
posterior uveitis.15 Functional study of the CCL2 gene has
shown that polymorphism at position 2518 correlates with
differences in the production of CCL2/MCP-1 by monocytes,
which in turn lead to variation in inflammatory response.12
Rovin et al.12 have shown that monocytes of individuals with
CCL2 2518G heterozygosity or homozygosity produced more
MCP-1 than monocytes from individuals homozygous for AA
after an inflammatory stimulus. Besides the CCL2 2518 poly-
morphism, Yeo et al.16 have found that the frequency of the T
allele of CCL2 2076 was significant higher in control subjects
than in patients with AU. Therefore the T allele at 2076 may
be protective against AU. However, in our study, CCL2
2076TT homozygosity was not present in both patients and
control subjects, and we did not observe a difference in both
the genotype and allele frequencies of the CCL2 2076 poly-
morphism between patients with AU and control subjects. It
was consistent with previous findings that the CCL2 2076
polymorphism did not affect the production of MCP-1.12
CCL5 is expressed in T lymphocytes, and polymorphism at
position 403 in the proximal promoter of the CCL5 gene has
been identified to be associated with atopic dermatitis.13
Nickel et al.13 have shown that the T allele at 403 is associ-
ated with an increased expression of the CCL5 gene in both
HMC and Jurkat T-cell lines through the regulation of the
GATA-binding transcription factors. In EAU, CCL5 was found to
be upregulated before the onset of uveitis, and its expression
correlated with the intensity of inflammation in the eyes and
central nervous system.11 However, in patients with posterior
uveitis, the 403T allele was found to be associated with less
intense inflammation, and patients with the T allele had better
visual acuity than did patients with the CC genotype.15 In the
present study, no significant association was found between
TABLE 1. Comparison of Genotype and Allele Frequencies of the MnSOD 47G/A, CCL2 2518A/G,










AA 65 (82.3) 146 (70.9) 1.00*†
AG 12 (15.2) 53 (25.7) 0.049‡§ 1.91 (1.00–3.66)
GG 2 (2.5) 7 (3.4)
Allele
A 142 (89.9) 345 (83.7) 0.063§
G 16 (10.1) 67 (16.3)
CCL2 2518A/G
Genotype
AA 15 (19.0) 58 (28.2) 0.11*§
AG 36 (45.6) 102 (49.5) 0.024‡§ 1.91 (1.09–3.36)
GG 28 (35.4) 46 (22.3)
Allele
A 66 (41.8) 218 (52.9) 0.017§ 1.57 (1.08–2.27)
G 92 (58.2) 194 (47.1)
CCL2 2076A/T
Genotype
AA 69 (87.3) 169 (82.0)
AT 10 (12.7) 37 (18.0) 0.28‡§
TT 0 (0) 0 (0.0)
Allele
A 148 (93.7) 375 (91.0) 0.30§
T 10 (6.3) 37 (9.0)
CCL5 403C/T
Genotype
CC 37 (46.8) 88 (42.7) 0.37*†
CT 37 (46.8) 97 (47.1) 0.53‡§
TT 5 (6.3) 21 (10.2)
Allele
C 111 (70.3) 273 (66.3) 0.36§
T 47 (29.7) 139 (33.7)
Data are the number of subjects (% of the total group).
* P-value for dominant model.
† Fisher exact test.
‡ P-value for recessive model.
§ 2 test.
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the genotype of 403T allele and AU. The frequency of TT
genotype is significant lower in Caucasian populations com-
pared with Asian populations and the CC genotype is more
commonly found in Caucasians. The differences in genetic
variations across different ethnic groups may be one of the
explanations for the lack of association found in our study. This
emphasizes the importance of studying the association of var-
ious polymorphisms associated with uveitis across different
populations.
In additional analyses, we stratified the patients with AU
depending on their HLA-B27 status. We found that the MnSOD
47A SNP was significantly associated with AU in HLA-B27–
positive patients, but not in HLA-B27–negative patients. On the
contrary, the CCL2 2518G polymorphism was significantly
associated with AU in HLA-B27–negative patients, but not in
HLA-B27–positive patients. This is in contrast with the findings
by Wegscheider et al.,6 in which the CCL2 2518G polymor-
phism was found to be associated with HLA-B27–associated
uveitis. The exact reason for the difference is unclear, but it
may be related to ethnic differences. Our findings suggest that
the influence of MnSOD and CCL2 polymorphisms on AU may
differ, depending on HLA-B27 status.
There were several limitations in the present study. First,
the relatively small sample size may lower the statistical power
of our study and therefore weaker associations between AU
and the genotypes may not be detected. Moreover, as several
different SNPs were assessed in this relatively small sample of
subjects, some of the P values would not remain statistically
TABLE 2. Comparison of Genotype and Allele Frequencies of the MnSOD 47G/A and CCL2 2518A/G











AA 32 (88.9) 146 (70.9) 0.024† 3.29 (1.11–9.70)
AG 3 (8.3) 53 (25.7) 1.00‡
GG 1 (2.8) 7 (3.4)
Allele
A 67 (93.1) 345 (83.7) 0.047 2.60 (1.01–6.80)
G 5 (6.9) 67 (16.3)
CCL2 2518A/G
Genotype
AA 8 (22.2) 58 (28.2) 0.83†
AG 19 (52.8) 102 (49.5) 0.55‡
GG 9 (25.0) 46 (22.3)
Allele
A 35 (48.6) 218 (52.9)
G 37 (51.4) 194 (47.1) 0.50
Data are the number of subjects (% of total group).
* Fisher exact test.
† P-value for the recessive model.
‡ P-value for the dominant model.
TABLE 3. Comparison of Genotype and Allele Frequencies of the MnSOD 47G/A and CCL2 2518A/G











AA 33 (76.7) 146 (70.9) 0.44†
AG 9 (20.9) 53 (25.7) 1.00‡
GG 1 (2.3) 7 (3.4)
Allele
A 75 (87.2) 345 (83.7) 0.42
G 11 (12.8) 67 (16.3)
CCL2 2518A/G
Genotype
AA 7 (16.3) 58 (28.2)
AG 17 (39.5) 102 (49.5) 0.13‡
GG 19 (44.2) 46 (22.3) 0.003† 2.75 (1.39–5.47)
Allele
A 31 (36.0) 218 (52.9)
G 55 (64.0) 194 (47.1) 0.004 1.99 (1.23–3.23)
Data are the number of subjects (% of total group).
* Fisher exact test.
† P-value for the recessive model.
‡ P-value for the dominant model.
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significant when adjusted for multiple testing and therefore the
results should be interpreted cautiously. In addition, the four
SNPs selected in the study will not reflect the disease risk of
unexamined variants in the genes in view of potential differ-
ences in linkage disequilibrium coverage. Further examination
of these SNPs as well as other gene variants in MnSOD and
chemokine genes in a larger group of patients with AU may
help to identify more genetic associations with AU.
In conclusion, we found significant association of the poly-
morphisms in the MnSOD 47 and CCL2 2518 SNPs with AU
in Chinese patients. The MnSOD 47A polymorphism appeared
to increase the risk of AU in HLA-B27–positive patients,
whereas the CCL2 2518G polymorphism was associated with
the increased risk of AU in HLA-B27–negative patients. Further
studies are needed to determine the interactions between the
MnSOD and CCL2 polymorphisms and the HLA-B27 status of
the patients.
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